Breast Cancer News and Research RSS Feed - Breast Cancer News and Research Twitter

Breast cancer is cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It occurs in both men and women, although male breast cancer is rare. When breast cancer cells spread to other parts of the body, they are called metastases. There are different kinds of breast cancer. The kind of breast cancer depends on which cells in the breast turn into cancer. Breast cancer can begin in different parts of the breast, like the ducts or the lobes.
UAB research findings may lead to better treatment for women with HER2+ breast cancer

UAB research findings may lead to better treatment for women with HER2+ breast cancer

There are five subtypes of breast cancer, and they are distinct diseases with vastly different biologies that drastically alter their progression and responses to treatment. Understanding those differences is the starting point to a more effective, personalized treatment of breast cancer, which strikes more than 230,000 women in the U.S. each year. [More]
Two UC Davis researchers awarded grant to help improve surveillance for patients with small lung nodules

Two UC Davis researchers awarded grant to help improve surveillance for patients with small lung nodules

Two UC Davis researchers will help run a major national study to improve surveillance practices for patients with small lung nodules identified on CT imaging and extremely low risk for lung cancer. [More]
Scientists identify way to potentially predict progression in patients with early form of breast cancer

Scientists identify way to potentially predict progression in patients with early form of breast cancer

Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression. [More]
New metabolic blood profile method could help predict breast cancer

New metabolic blood profile method could help predict breast cancer

According to the World Health Organization, breast cancer is the most common cancer in women both in the developed and less developed world, and in the long term the scientists hope that the new method will lead to better prevention and early treatment of the disease. [More]
New combination therapy holds promise for treating HER2-positive breast cancer

New combination therapy holds promise for treating HER2-positive breast cancer

Resistance to therapy is a major problem in the cancer field. Even when a treatment initially works, the tumors often find ways around the therapy. [More]
Vascular mimicry can spread breast cancer to other sites

Vascular mimicry can spread breast cancer to other sites

Imitation may be the sincerest form of flattery, but it can also have deadly consequences, at least when it comes to tumor cells. [More]
Bright Pink, David's Bridal team up to raise awareness on breast and ovarian cancer

Bright Pink, David's Bridal team up to raise awareness on breast and ovarian cancer

It's time to pucker up for a cause! Beginning today, David's Bridal will donate $1 (up to $100,000) to Bright Pink for every kiss sent on Instagram and Twitter using the hashtag #WithAKiss! [More]
Stem cell disease model reveals how tumor suppressor may drive bone cancer

Stem cell disease model reveals how tumor suppressor may drive bone cancer

Using induced pluripotent stem cells (iPSCs), a team led by Mount Sinai researchers has gained new insight into genetic changes that may turn a well known anti-cancer signaling gene into a driver of risk for bone cancers, where the survival rate has not improved in 40 years despite treatment advances. [More]
MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced at the St. Gallen International Breast Cancer Conference that new guidelines of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) recommend the MammaPrint® 70-gene breast cancer recurrence assay in Germany’s 2015 guidelines for early-stage invasive breast cancer. [More]
Yale University-led research explores directional cues that influence cancer cells

Yale University-led research explores directional cues that influence cancer cells

Scientists are mapping the habits of cancer cells, turn by microscopic turn. Using advanced technology and an approach that merges engineering and medicine, a Yale University-led team has compiled some of the most sophisticated data yet on the elaborate signaling networks directing highly invasive cancer cells. Think of it as a digital field guide for a deadly scourge. [More]
Researchers find Fountain of Youth while conducting breast cancer research

Researchers find Fountain of Youth while conducting breast cancer research

The Fountain of Youth has been discovered and it's not in Florida as Ponce de Leon claimed. Instead, it was found in the mammary glands of genetically modified mice. [More]
Sensor system helps physicians improve quality of clinical breast examinations

Sensor system helps physicians improve quality of clinical breast examinations

NIBIB-funded researchers have developed a highly effective sensor system to improve the quality of clinical breast examinations by physicians. The training system addresses a critical need for physicians to develop the technique and skill necessary to consistently detect the presence of breast lesions during a clinical breast exam (CBE). [More]
Women with inherited BRCA1/2 mutations at increased risk of breast and ovarian cancers

Women with inherited BRCA1/2 mutations at increased risk of breast and ovarian cancers

In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA. [More]
Quebec Breast Cancer Foundation announces $4.5M investment for 9 homegrown researchers

Quebec Breast Cancer Foundation announces $4.5M investment for 9 homegrown researchers

The Quebec Breast Cancer Foundation is proud to announce a $4.5 million investment for 9 homegrown researchers, thanks to the continued generosity of its donors and partners. [More]
CVS Health Foundation announces new grant recipients to increase access to health care

CVS Health Foundation announces new grant recipients to increase access to health care

The CVS Health Foundation, a private foundation created by CVS Health Corporation (NYSE: CVS), today announced 55 new grant recipients as part of its multi-year, $5 million commitment to increase access to health care in communities nationwide. [More]
Around 90% of all breast cancers can be diagnosed using MRI, shows study

Around 90% of all breast cancers can be diagnosed using MRI, shows study

Around 90 per cent of all breast cancers can be definitively diagnosed using magnetic resonance imaging (MRI). This compares to the combined methods of mammography and ultrasound which yielded a detection rate of just 37.5 per cent. [More]
Many women diagnosed with breast cancer concerned about genetic risk of developing other cancers

Many women diagnosed with breast cancer concerned about genetic risk of developing other cancers

A new study from the University of Michigan Comprehensive Cancer Center finds that many women diagnosed with breast cancer are concerned about the genetic risk of developing other cancers themselves or of a loved one developing cancer. [More]
Mayo Clinic-led researchers combine genetic variants to improve identification of women with breast cancer

Mayo Clinic-led researchers combine genetic variants to improve identification of women with breast cancer

Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person's overall risk of developing the disease. [More]
Combination of signaling molecules can inhibit growth of breast cancer cells

Combination of signaling molecules can inhibit growth of breast cancer cells

Researchers at UT Southwestern Medical Center have uncovered how the body's inflammatory response can alter how estrogen promotes the growth of breast cancer cells. [More]
Pyrexar Medical procures hyperthermia assets of BSD Medical, begins operations

Pyrexar Medical procures hyperthermia assets of BSD Medical, begins operations

Pyrexar Medical begins operations today after completing the acquisition of hyperthermia assets held by Perseon, formerly BSD Medical. This acquisition includes substantially all hyperthermia assets, products, services and related intellectual property. [More]
Advertisement
Advertisement